Adverum Biotechnologies Inc (NASDAQ:ADVM)

Delayed Data
As of Jul 06
 +0.07 / +6.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Adverum Biotechnologies Inc have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +144.90% increase from the last price of 1.23.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Adverum Biotechnologies Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.53%
Growthannually 2.36%


Growthquarterly --
Growthannually -100.00%
Key to the earnings and sales forecast charts.